Chattem Sanofi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHATTEM SANOFI, and what generic alternatives to CHATTEM SANOFI drugs are available?
CHATTEM SANOFI has eighteen approved drugs.
There are two US patents protecting CHATTEM SANOFI drugs.
There are sixty-seven patent family members on CHATTEM SANOFI drugs in forty countries and two supplementary protection certificates in two countries.
Summary for Chattem Sanofi
International Patents: | 67 |
US Patents: | 2 |
Tradenames: | 15 |
Ingredients: | 7 |
NDAs: | 18 |
Drugs and US Patents for Chattem Sanofi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-006 | Aug 2, 1996 | OTC | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chattem Sanofi | ALLEGRA HIVES | fexofenadine hydrochloride | TABLET;ORAL | 020872-008 | Jan 24, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chattem Sanofi | XYZAL | levocetirizine dihydrochloride | TABLET;ORAL | 022064-001 | May 25, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chattem Sanofi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-006 | Aug 2, 1996 | 5,004,610 | ⤷ Try a Trial |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | 5,855,912*PED | ⤷ Try a Trial |
Chattem Sanofi | ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021704-002 | Jan 24, 2011 | 6,613,357 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHATTEM SANOFI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Transdermal System | 7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs | ➤ Subscribe | 2014-05-30 |
➤ Subscribe | Tablets | 5 mg | ➤ Subscribe | 2007-12-17 |
➤ Subscribe | Oral Suspension | 30 mg/5 mL | ➤ Subscribe | 2010-01-25 |
➤ Subscribe | Oral Solution | 0.5 mg/mL | ➤ Subscribe | 2009-01-14 |
➤ Subscribe | Tablets | 150 mg | ➤ Subscribe | 2007-10-30 |
International Patents for Chattem Sanofi Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Israel | 192067 | ⤷ Try a Trial |
Australia | 2005261953 | ⤷ Try a Trial |
Australia | 2006326551 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chattem Sanofi Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0663828 | C300085 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
0058146 | 2001C/045 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.